(Q54138576)

English

Abacavir.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

25 May 2018

http://europepmc.org/abstract/MED/9585869

1 reference

Europe PubMed Central

Abacavir. (English)

1 reference

Europe PubMed Central

PubMed publication ID

25 May 2018

http://europepmc.org/abstract/MED/9585869

author name string

R H Foster

1

1 reference

Europe PubMed Central

PubMed publication ID

25 May 2018

http://europepmc.org/abstract/MED/9585869

D Faulds

2

1 reference

Europe PubMed Central

PubMed publication ID

25 May 2018

http://europepmc.org/abstract/MED/9585869

publication date

1 May 1998

1 reference

Europe PubMed Central

PubMed publication ID

25 May 2018

http://europepmc.org/abstract/MED/9585869

1 reference

Europe PubMed Central

PubMed publication ID

25 May 2018

http://europepmc.org/abstract/MED/9585869

55

1 reference

Europe PubMed Central

PubMed publication ID

25 May 2018

http://europepmc.org/abstract/MED/9585869

5

1 reference

Europe PubMed Central

PubMed publication ID

25 May 2018

http://europepmc.org/abstract/MED/9585869

729-36; discussion 737-8

1 reference

Europe PubMed Central

PubMed publication ID

25 May 2018

http://europepmc.org/abstract/MED/9585869

https://scigraph.springernature.com/pub.10.2165/00003495-199855050-00018

0 references

1592U89, a novel carbocyclic nucleoside analog with potent, selective anti-human immunodeficiency virus activity

1 reference

https://pubmed.ncbi.nlm.nih.gov/9585869

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

British HIV Association guidelines for antiretroviral treatment of HIV seropositive individuals. BHIVA Guidelines Co-ordinating Committee

1 reference

https://pubmed.ncbi.nlm.nih.gov/9585869

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Unique intracellular activation of the potent anti-human immunodeficiency virus agent 1592U89

1 reference

https://pubmed.ncbi.nlm.nih.gov/9585869

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Antiretroviral therapy for HIV infection in 1997. Updated recommendations of the International AIDS Society-USA panel

1 reference

https://pubmed.ncbi.nlm.nih.gov/9585869

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Combination of mutations in human immunodeficiency virus type 1 reverse transcriptase required for resistance to the carbocyclic nucleoside 1592U89

1 reference

https://pubmed.ncbi.nlm.nih.gov/9585869

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

In vitro antiviral activity of 141W94 (VX-478) in combination with other antiretroviral agents

1 reference

https://pubmed.ncbi.nlm.nih.gov/9585869

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.2165/00003495-199855050-00018

1 reference

Europe PubMed Central

PubMed publication ID

25 May 2018

http://europepmc.org/abstract/MED/9585869

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

25 May 2018

http://europepmc.org/abstract/MED/9585869

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q54138576&oldid=1389945206"